Tell us about your organization

 
 

Tell us about you

Work Email required

Organization required

First Name required

Last Name required

Job Title required

Phone required (###) ###-####, or int ######...

City required

State/Province required

Business Information

error messages will go here...

Looks like we’re already familiar with you!

Please press next to continue with the survey.

Looks like we’re already familiar with you!

According to your account type you are not eligible to take surveys at this time. If this is a mistake, please contact KLAS.

If you are trying to access KLAS research data and reports, an email has been sent to   with a link to login.

If the email doesn't appear in your inbox, ask your IT department to add KLASresearch.com to your company spam filter's "whitelist", and check your email's spam folder.

Membership Commitment

In exchange for giving their feedback, healthcare providers can create an account to get access to industry reports, user commentary, and real-time ratings.

By submitting your account request, you are engaged in patient care as either an employee (or contractor) of your provider organization and that you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically. To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

Thank You! Your information was submitted successfully!

Next Steps - An email has been sent to . Please follow its instructions to verify your email, and login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank You! Your information was submitted successfully!

Next Steps - A KLAS representative will contact you to discuss working with KLAS, typically within 24 to 48 hours.

If you have any further questions please contact info@klasresearch.com or 1-800-920-4109.

Surprise! Looks like we already have an account for you.

An email has been sent to blah@blah.com with a link to login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank you !

Access info about on your dashboard or bookmark under

(Your Products / Your Organization's Products)

Jvion

Headquarters:

Suwanee Georgia, United States

Sector Funding:

Go to Website

Jvion's Current COVID-19 Response and Solutions

The following information was supplied by the vendor and has not been validated by KLAS.

COVID-19 Patient Vulnerability List
Data insights to support a shift from a reactive to proactive pandemic response

Assessment of propensity for poor outcomes can assist health systems in planning and deploying resources to optimize the health impact in reducing risk across a vulnerable population in the face of limited resources. Jvion is leveraging its AI capabilities to provide health systems with the opportunity to leverage data insights to support a shift from a reactive to proactive pandemic response.

COVID-19 Patient Vulnerability List is a roster of community members who are most at risk for a severe course of COVID-19 if infected. Those patients should change behaviors to self-isolation practices. The list incorporates both clinical and socioeconomic data and provides an opportunity to engage with automated patient engagement solutions

How Will the Insights Be Delivered?

  • Initially, a list of high-risk patients for severe outcomes with COVID-19 will be delivered either by Jvion’s portal or via a flat file.
  • The number of patients and filter parameters for the list can be determined by the customer preference.

What Client Data Is Utilized?

  • Claims data consistent with minimum requirements for avoidable admissions, avoidable ED visits, and all-cause readmissions vectors will be used.

How Is the List Maintained?

  • The list will mature over time, reflecting the AI learnings from the Jvion machine. It will be updated and distributed to our customers on a regular basis.

What Is the Timeline for Delivery?

  • The first lists for early adopters were delivered on March 20.
  • Subsequent delivery will occur for a second wave of adopters and rolled out across the broader base as available.

How Does the Solution Work?

  • Jvion will provide patient-level insight based on a variety of risk factors that could potentially lead to COVID-19 morbidity and mortality. This level of granularity enables the healthcare organization to take specific actions (e.g., calling patients with a specific message regarding preventive-action recommendations).
  • The insights are based on the data contained in the Jvion machine, including roughly 30 million patient records and thousands of related data points, to reduce bias in the list when generated.
  • We are using a parallel target of poor outcomes from influenza viral infections to estimate risk. The Jvion machine will learn more as more cases of COVID-19 are identified and tracked.

Is There a Cost for the List?

  • The list is available to existing customers at no cost. New customer pricing is available upon request.

What Are the Anticipated Benefits?

  • Proactive approach to reducing viral spread among vulnerable populations.
  • Reduced inpatient utilization by the most at-risk populations with targeted prevention and early intervention.
  • Allocation of resources to those patients with most severe cases of illness.

Will There Be Publicly Available Tools?

  • Yes. Jvion is developing a community vulnerability map to complement the risk lists for those who cannot yet gain actionable, individual-level insights.

Thank you !

Access info about on your dashboard or bookmark under

(Your Products / Your Organization's Products)

Software Overall Score Data collected between Jan 2020 - Jan 2021

78

 Product
Segment
 

Exceptions

R
Regional Classification
C
Component Products
S
Superseded Products
NP
Not Primary Products
DR
Data Review
MS
Limited Market Share
FR
Data frozen, live data no longer collected.

The following exceptions refer to the number of unique organizations contributing evaluations to the overall score (minimum of 15 required).

# of Unique Organization Evaluations:

0 - 5
L 6 - 14

Segment Position

Segment positions refer to the order in which this product is scored among competitors’ products within its market segment.

In order to be scored in a segment, the product must have sufficient data levels and be equivalent in scope to other products within that segment.

Click the segment positions listed below to learn more.